Skip to main content
Clinical Trials/CTRI/2020/06/025898
CTRI/2020/06/025898
Not yet recruiting
Phase 3

A Multi-Centre Study: Comparison of Marma Therapy and Mukta Vati in The Treatment of Stage I Hypertension

Patanjali Research Institute Haridwar0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Sponsor
Patanjali Research Institute Haridwar
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Patanjali Research Institute Haridwar

Eligibility Criteria

Inclusion Criteria

  • Subjects will be enrolled with stage I HTN.
  • Subjects who are drug\-naïve will be enrolled for the study with normal LV function.

Exclusion Criteria

  • LVEF \< 50%
  • CKD, Serum creatinine \> 1\.7

Outcomes

Primary Outcomes

Not specified

Similar Trials